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Abstract
Introduction: The aim of this study is to analyze 12 late conversion to open surgery after Endovascular Repair of
Abdominal Aortic Aneurysms (EVAR) while comparing the follow up of these cases to that of the definitely
successful procedures (absence of surgical conversion, type I or III endoleaks, or presence of type II endoleaks
without any aneurysmal sac enlargement) .
Methods: From a series of over 300 EVAR procedures performed at our department we have selected 215 cases
with a follow up ≥ 6 month and primary technical success (successful deployment of the devices and discharge of
patients without neither type I nor III endoleaks). Based on the final data recorded at the end of the follow up (mean+
IQR: 38.16 months + 41), these cases were divided into three groups: group 1, with 12 cases (5.6%) which needed
surgical conversion in a later stage (5 to 55 months from EVAR); group 2, with 39 cases (18.1%) with type II
endoleaks without aneurysmal sac enlargement; group 3, with 164 cases (76.5%) without endoleaks. The groups
were compared in relation to the following parameters: a) personal data and common atherogenic risk factor, b)
diameter of the aneurysm, c) kind of the proximal fixation of the endograft (suprarenal or infrarenal), d) presence of
endoleaks at the first postoperative check. We have compared the data from the three groups and we have
analyzed them with chi-square test (Χ2).
Results: Personal data and common atherogenic risk factor have proved no significant difference among the
three groups. The incidence of the other three parameters of group 1 was compared with the incidence of these in
groups 2 and 3: the mean pre-operative diameter of the aneurysm results 51 mm in group 1, 54 mm in group 2 and
55 mm in group 3 (not significant); suprarenal fixation of the prosthesis accounts for 50% in group 1, 51% in group 2
and 60% in group 3 (not significant); presence of type II endoleak at the first post-operative check was 41.6% in
group 1, 56.4% in group 2 (not significant) and 9.7% in group 3 (p<0.001, compared to groups 1 and 2).
Conclusion: In the EVAR procedures with primary technical success, the absence of type II endoleak at the first
post-operative check represents a favorable prognostic factor against the risk of late conversion to open repair.
Personal data, common atherogenic risk factor, diameter of the aneurysm and fixing type of the prosthesis don’t
seem to influence the onset of this complication.
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Introduction
Endovascular Abdominal Aortic Repair (EVAR) has established
over time as an effective and safe method to treat abdominal aortic
aneurysms. This technique ensures a reduced perioperative morbidity
and mortality compared to the traditional surgical technique,
especially in elderly patients with significant comorbidities [1,2].
Patients who have undergone endovascular treatment need lifelong
surveillance, in order to prevent and treat potential complications,
including endoleak, increase in aneurysm size, graft migration,
structural graft failure and limb stenosis or occlusion. The presence of
these complications, in a small percentage of cases, can results in a late
conversion to open repair [3]. The aim of this study is to analyze 12
EVAR with late conversion in comparison with 203 cases with long-
term good results.
Methods
Our EVAR database compiled in a prospective, real time manner
was reviewed. From a series of over 300 consecutively performed
EVAR procedures, 215 cases with a follow up ≥ 6 months were
considered. Regarding the indication for EVAR we closely followed
the international guidelines, selecting patients with asymptomatic
abdominal aortic aneurysm greater than 5 cm in an orthogonal
projection or an aneurysm diameter of 4-5 cm, which has increased in
size by 0.5 cm in last six months or in presence of blister/bubbles. The
patient should have a proximal landing zone (distal to the lower renal
artery) of at least 1.5 cm without significant calcification or thrombus,
and similarly a distal landing zone of at least 2.5 cm. The proximal
neck angulation should be less than 45 degrees, and the patient should
have access vessels of at least 6-8 mm luminal diameter (depending on
the manufacturer’s requirements) and without extreme tortuosity. The
lower diameter of treated aneurysms was 42 mm, the largest 75 mm. In
the 215 cases considered, we used the following devices: Anaconda (3
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cases), Aneurx (19 cases), Aorfix (4 cases), Endologix (2 cases),
Medtronic Endurant (32 cases), Gore Excluder (65 cases), Medtronic
Talent (89 cases); Zenith Cook (1 case); between these, the device used
in the converted cases was AneuRx (3 cases), Excluder (1 case) or
Talent (8 cases).
Usually, we recommend to all patients undergoing EVAR
antiplatelet therapy (with acetylsalicylic acid or ticlopidine or
clopidogrel) if it is not already in use oral anticoagulant therapy. All
selected cases had obtained primary technical success (successful
deployment of the devices in absence of surgical conversion, type I or
III endoleaks). The follow up protocol included clinical and
instrumental examinations at 3,6,12 months and yearly thereafter. All
patients underwent follow-up by CT angiography at first. If after 2-3
consecutive CT checks there was no evidence of endoleaks and there
was shrinkage of the excluded aneurysm sac, we performed the
following control by Duplex Ultrasound. We used magnetic resonance
imaging in cases of allergy to iodinated contrast.
Based on the last data collected at the end of the follow up, the 215
cases were divided into three groups: group 1, with 12 cases (5.6%)
with type I (4 cases), II(7 cases) or III(1 case) endoleaks and
aneurysmal sac enlargement, and therefore ended with open surgical
conversion; group 2, including 39 cases (18.1%) with type II endoleaks
without aneurysmal sac enlargement; group 3, including 164 cases
(76.5%) without endoleaks. Each group was evaluated in relation to
personal data and common atherogenic risk factor, diameter of the
aneurysm, fixation of the prosthesis (suprarenal or infrarenal), and
presence of endoleaks at the first postoperative control. At the end the
characteristics of the 12 converted cases were compared to that of the
successful procedures of Group 2 and 3.
Results
In group 1 there were 4 cases of type I endoleak not treatable with
endovascular skills and 7 cases of type II endoleak with sac
enlargement, 1 case of type III endoleak subsequent to a persistent
type II endoleak lasting more than 2 years after EVAR. Out of seven
cases of type II endoleaks, 2 cases weren’t suitable for angiographic
treatment, because of an unfavorable anatomy of the ileo-lumbar
circle, 4 had been subjected to unsuccessful angiographic treatment
(lumbar arteries embolization with coils); 1 patient had undergone
inferior mesenteric artery laparoscopic ligation. The kind of device
used in this group of patients was AneuRx (3 cases), Excluder (1 case)
or Talent (8 cases). The average time between EVAR and conversion
to open repair was 55.6 months (range 5 – 120 months) (Table 1). The
comparison of the groups in regards to personal data of the patients,
common atherogenic risk factors, mean diameters of the aneurysms
and kind of proximal fixation of the endoprosthesis has not revealed
significant differences (Table 2): male gender was 100% in group 1,
93.8% in group 2 and 94.1% in group 3. The average age of the patients
was 74.6 years in group 1, 73.1 years in group 2, 75.2 years in group 3.
Smoking History was present in 41.6% of patients in group 1, 44.8% in
group 2 and 41.3% in group 3. Hypertension affected 75% of patients
in group 1, 73.4% in group 2 and 72.4% in group 3. Renal Insufficiency
was present in 16.7% of patients in group 1, 16.3% in group 2 and 10%
in group 3. The mean pre-operative diameter of the aneurysm resulted
51mm in group 1, 54mm in group 2 and 55mm in group 3. Suprarenal
fixation of the prosthesis accounted for 50% in group 1, 51% in group
2 and 60% in group 3. The only significant difference between the
analyzed groups consists in the low rate of type II endoleak at the first
post-operative check in Group 3 (9.7%), compared both with 41.6% in
Group 1 and 56.4% in Group 2 (p>0.001).
Features of 12 Converted Cases (group 1)
Endoleak Type i – 4
Type ii – 7
Type iii – 1 (previous type ii endoleak)
Device Aneurx – 3
Talent – 8
Excluder – 1
Average time (month) between evar and conversion 55.6
Treatment of type ii endoleak Lumbar arteries embolization – 5
Failed attempts to embolization - 2
Ami laparoscopic ligation – 1
Table 1: Features of the Converted Cases
 Group 1 Group 2 Group 3
N° Patient 12 39 164
a) Pre-Operative Diameter 51 54 55
b) Device Fixation
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Suprarenal 6 20 99
Infrarenal 6 19 65
c) Type Ii Endoleak (1st post-operative control)
No 7 17 148
Yes 5 22 16
Table 2: Comparison between the 3 groups
Discussion
Starting from the first interventions more than 20 years ago [4],
technological advances have allowed EVAR to become the most
common method to treat infrarenal abdominal aortic aneurysm with
good short term and acceptable long term outcomes, as reported in
literature [1]. Despite technological advances, a fair percentage of
patients need further treatment following EVAR and this is the reason
why lifelong radiographic surveillance is mandatory after this kind of
procedure [5]. In the randomized EVAR-1 trial, the rate of late
conversion (beyond the initial 30 postoperative days) to open repair
was 2.6%, with a mean delay of 3.3 years after first repair [1]. Late
conversion has been reported in literature as the follow up to 9% of
EVAR [6]: our conversion rate (5.58%) falls within that range.Data
emerging from our series suggest that age, gender, common
atherogenic risk factors of the patients, as well as diameter of the
aneurysm and type of endograft proximal fixation, do not significantly
affect the post-operative outcome. The presence of type II endoleak at
the first post-operative control seems to be related with late adverse
outcome after EVAR (a statistically significant difference between
group 3 and group 1 and 2 is observed). It is rather common
knowledge that clinical impact of type II endoleak after EVAR is not
well established and remains highly controversial [7-10]. First of all,
the incidence of type II endoleak oscillates greatly from 6% to up to
30% in large series of EVAR patients [11,12]. Secondly, published
reports demonstrated that spontaneous resolution of endoleaks can
sometimes occur, even if this is not associated with constant rates of
occurence (5-33%) [13]. Furtherly, most of the authors assert that type
II endoleak is a minor complication not necessarily related to an
increase in aneurysms size [14-16]. Actually, EUROSTAR series had
reported a significantly higher rate of re-intervention required by
patients with type II endoleaks, but did not find a direct correlation
between this type of endoleak and conversion to open repair or
rupture. Jones at al demonstrated the negative impact of type II
endoleaks in increasing risk of aneurysm rupture, sac grow,
conversion to open repair, compared with patients without endoleaks
[17]. In the series reported by Jones et al. 3 out of 33 patients with a
persistent type 2 endoleak required a conversion to open repair, while
aneurysm rupture occurred in four patients with an early type 2
endoleak. Statistical analysis showed them that patients with a
persistent type 2 endoleak had a significantly higher rate of conversion
to open repair compared with those without an early endoleak (RR,
5.3; 95% CI, 2.0 to 13.5; P 0.001) and patients with a persistent type 2
endoleak had a higher rate of rupture compared to those without early
endoleak (RR, 3.9; 95% CI, 1.7 to 8.8; P 0.03). Our data does not
confirm Jones’ conclusions, because we found a significant rate of type
II endoleak also in group 2, which doesn’t show any sac enlargement:
18.1% to 56.1% at the first postoperative check, but still significant at
the end of the follow up. On the other hand, the significant lower rate
of primary type II endoleak in group 3 (9.6%) leads us to believe that
the absence of this kind of leak after EVAR is an effective protective
factor from the risk of late conversion. Recently, Nolz et al. stated that
- in the long term - follow up persistent type II endoleak leads to
significant aneurysm sac enlargement in comparison with aneurysm
with transient endoleak or its absence. Close surveillance seems to be
advisable in aneurysms with persistent type II endoleak only [18].
Therefore, just after the first check, it would seem sensible to put the
majority of efforts into performing a strict follow up in cases with
endoleak II only, whilst it would be reasonable to reduce the frequency
of the subsequent checks in patients who show the protective factor, in
the form of the absence of type II endoleak at the first postoperative
check.
Conclusion
In the EVAR procedures with primary technical success, the
absence of type II endoleak at first post-operative check represents a
favorable prognostic factor against the risk of late conversion to open
repair and it allows to reduce the rate of subsequent radiological
checks, while personal data, common atherogenic risk factor, diameter
of the aneurysm and fixing type of the prosthesis don’t seem to
influence the onset of this complication.
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